Skip to Content

WATSON 493 250 mg (Mexiletine hydrochloride 250 mg)

Pill with imprint WATSON 493 250 mg is Brown / Green, Capsule-shape and has been identified as Mexiletine hydrochloride 250 mg. It is supplied by Watson Laboratories, Inc..

Mexiletine is used in the treatment of diabetic peripheral neuropathy; myotonia congenita; ventricular tachycardia; arrhythmia and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Mexiletine 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for WATSON 493 250 mg

Mexiletine hydrochloride

Imprint:
WATSON 493 250 mg
Strength:
250 mg
Color:
Brown / Green
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Group I antiarrhythmics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Watson Laboratories, Inc.
National Drug Code (NDC):
00591-0493

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide